Zampi Jeffrey D, Ilardi Dawn L, McCracken Courtney E, Zhang Yun, Glatz Andrew C, Goldstein Bryan H, Petit Christopher J, Qureshi Athar M, Goldberg Caren S, Law Mark A, Meadows Jeffery J, Shahanavaz Shabana, Batlivala Sarosh P, Maskatia Shiraz A, O'Byrne Michael L, Ligon R Allen, Pettus Joelle A, Beshish Asaad, Romano Jennifer C, Stack Kathryn O, Khan Hala Q, Parekh Shalin, Nicholson George T
Division of Cardiology, Department of Pediatrics, C.S. Mott Children's Hospital, University of Michigan School of Medicine, Ann Arbor, MI.
Pediatric Neurodevelopmental Center, Atlanta, GA; Children's Heart Center Cardiology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.
J Pediatr. 2025 Jan;276:114357. doi: 10.1016/j.jpeds.2024.114357. Epub 2024 Oct 16.
To assess the association between primary and staged repair of neonatal symptomatic tetralogy of Fallot (sTOF) and neurodevelopmental outcomes in preschool through school-age children.
Multicenter cohort (n = 9 sites) study of patients with sTOF who underwent neonatal intervention between 2005 and 2017. The neurodevelopmental outcomes measures included caregivers' ratings of executive function with the Behavior Rating Inventory of Executive Function, and psychosocial functioning with the Behavior Assessment System for Children - third Edition (BASC-3). Results were compared with normative data and by treatment strategy (primary repair vs staged repair). A parent survey assessed history of disabilities and access to services related to neurodevelopment.
Although the majority of patients (median age 8.3 years, IQR 5.7-11.2) had median Behavior Rating Inventory of Executive Function and BASC-3 scores within the normal range, a proportion had clinically elevated (abnormal) scores, especially in the school-age patient subgroup (Behavior Rating Inventory of Executive Function 24%-30% and BASC 20%-37%). There were no statistically significant differences based on treatment strategy for either the Behavior Rating Inventory of Executive Function or BASC-3. However, lower birth weight, genetic syndrome, and medical complexity were significantly associated with worse executive function, and lower maternal education was associated in school-age children with lower executive and psychosocial functioning. Ongoing disabilities were relatively common (learning disability 35%, speech delay 33%, developmental delay 31%), although up to 50% of children were not receiving educational or developmental services.
Elevated executive and psychosocial concerns are present in the patient population with sTOF. Although initial treatment strategy appears unrelated to neurodevelopmental outcomes, lower birth weight, genetic syndrome, and medical complexity and lower maternal education are risk factors. Early recognition of neurodevelopmental concerns can facilitate access to appropriate neurodevelopmental services in this high-risk group.
评估新生儿症状性法洛四联症(sTOF)一期修复与分期修复和学龄前至学龄期儿童神经发育结局之间的关联。
对2005年至2017年间接受新生儿干预的sTOF患者进行多中心队列研究(n = 9个地点)。神经发育结局测量包括照顾者使用执行功能行为评定量表对执行功能的评分,以及使用儿童行为评估系统第三版(BASC - 3)对心理社会功能的评分。将结果与常模数据进行比较,并按治疗策略(一期修复与分期修复)进行比较。一项家长调查评估了残疾史以及获得与神经发育相关服务的情况。
尽管大多数患者(中位年龄8.3岁,四分位间距5.7 - 11.2岁)的执行功能行为评定量表和BASC - 3评分中位数在正常范围内,但仍有一部分患者的评分在临床上升高(异常),尤其是在学龄期患者亚组中(执行功能行为评定量表为24% - 30%,BASC为20% - 37%)。基于治疗策略,执行功能行为评定量表或BASC - 3均无统计学显著差异。然而,低出生体重、遗传综合征和医疗复杂性与较差的执行功能显著相关,而母亲教育程度较低与学龄期儿童较低的执行功能和心理社会功能相关。持续存在的残疾相对常见(学习障碍35%,语言延迟33%,发育迟缓31%),尽管高达50%的儿童未接受教育或发育服务。
sTOF患者群体中存在执行功能和心理社会方面的问题。尽管初始治疗策略似乎与神经发育结局无关,但低出生体重、遗传综合征、医疗复杂性和母亲教育程度较低是危险因素。早期识别神经发育问题有助于该高危群体获得适当的神经发育服务。